PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $335,823 | +2.4% | 10,946 | +33.8% | 0.00% | 0.0% |
| Q2 2023 | $327,853 | -1.8% | 8,182 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $333,907 | +17.8% | 8,182 | +11.4% | 0.00% | 0.0% |
| Q4 2022 | $283,513 | -21.2% | 7,343 | +8.6% | 0.00% | 0.0% |
| Q3 2022 | $360,000 | -8.6% | 6,761 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $394,000 | -24.1% | 6,761 | -0.6% | 0.00% | -33.3% |
| Q1 2022 | $519,000 | +37.3% | 6,800 | +8.3% | 0.00% | +50.0% |
| Q4 2021 | $378,000 | +69.5% | 6,280 | +57.9% | 0.00% | +100.0% |
| Q3 2021 | $223,000 | -7.5% | 3,978 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $241,000 | -13.6% | 3,978 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $279,000 | -16.0% | 3,978 | -28.2% | 0.00% | 0.0% |
| Q4 2020 | $332,000 | -0.3% | 5,544 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $333,000 | +14.4% | 5,544 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $291,000 | +80.7% | 5,544 | +15.7% | 0.00% | +50.0% |
| Q1 2020 | $161,000 | +50.5% | 4,790 | +102.8% | 0.00% | +100.0% |
| Q4 2019 | $107,000 | +18.9% | 2,362 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $90,000 | -12.6% | 2,362 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $103,000 | +14.4% | 2,362 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $90,000 | -29.1% | 2,362 | -19.9% | 0.00% | 0.0% |
| Q4 2018 | $127,000 | +6.7% | 2,950 | +22.3% | 0.00% | 0.0% |
| Q3 2018 | $119,000 | +85.9% | 2,412 | +21.6% | 0.00% | 0.0% |
| Q2 2018 | $64,000 | +3.2% | 1,984 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $62,000 | -31.9% | 1,984 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $91,000 | +65.5% | 1,984 | +35.1% | 0.00% | 0.0% |
| Q3 2017 | $55,000 | -21.4% | 1,468 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $70,000 | +22.8% | 1,468 | +16.8% | 0.00% | 0.0% |
| Q1 2017 | $57,000 | +39.0% | 1,257 | 0.0% | 0.00% | – |
| Q4 2016 | $41,000 | -4.7% | 1,257 | 0.0% | 0.00% | – |
| Q3 2016 | $43,000 | +16.2% | 1,257 | +13.4% | 0.00% | – |
| Q2 2016 | $37,000 | -37.3% | 1,108 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $59,000 | -30.6% | 1,108 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $85,000 | +466.7% | 1,108 | +202.7% | 0.00% | – |
| Q3 2015 | $15,000 | +50.0% | 366 | +147.3% | 0.00% | – |
| Q2 2015 | $10,000 | -23.1% | 148 | 0.0% | 0.00% | – |
| Q1 2015 | $13,000 | – | 148 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |